These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3515929)

  • 1. Metabolism and disposition of buspirone.
    Gammans RE; Mayol RF; LaBudde JA
    Am J Med; 1986 Mar; 80(3B):41-51. PubMed ID: 3515929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.
    Barbhaiya RH; Shukla UA; Pfeffer M; Pittman KA; Shrotriya R; Laroudie C; Gammans RE
    Eur J Clin Pharmacol; 1994; 46(1):41-7. PubMed ID: 7911763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
    Mahmood I; Sahajwalla C
    Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between buspirone bioavailability and dose in healthy subjects.
    Gammans RE; Mayol RF; Mackenthun AV; Sokya LF
    Biopharm Drug Dispos; 1985; 6(2):139-45. PubMed ID: 2860931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S; Muglia M; Mancinelli A; Garattini S
    Xenobiotica; 1983 Mar; 13(3):147-53. PubMed ID: 6613160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of oral buspirone in patients with impaired renal function.
    Caccia S; Vigano GL; Mingardi G; Garattini S; Gammans RE; Placchi M; Mayol RF; Pfeffer M
    Clin Pharmacokinet; 1988 Mar; 14(3):171-7. PubMed ID: 3370902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.
    Goldberg HL
    Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
    Stalker DJ; Jungbluth GL
    Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of remoxipride.
    von Bahr C; Movin G; Yisak WA; Jostell KG; Widman M
    Acta Psychiatr Scand Suppl; 1990; 358():41-4. PubMed ID: 1978486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration.
    Woodworth JR; Owens SM; Mayersohn M
    J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.
    Mealey KL; Peck KE; Bennett BS; Sellon RK; Swinney GR; Melzer K; Gokhale SA; Krone TM
    J Vet Intern Med; 2004; 18(1):43-6. PubMed ID: 14765730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.